CancerConnect
Top Stories
Newly Diagnosed
Treatment & Care
Survivorship
Comments

Pancreatic Cancer

FEATURED
COMMUNITY

PARP Inhibitors Shows Promise as Treatment for Pancreatic Cancer

PARP Inhibitor Lynparza - first precision cancer medicine approved for treatment of pancreatic cancer.

Cancer Connect

Pancreatic Cancer Treatment and Management

Understand the role of surgery, chemotherapy and precision cancer medicines for treatment of pancreatic cancer.

Cancer Connect

by

Juvanta

Overview of Pancreatic Cancer

Symptoms, risk factors, diagnosis, screening and prevention of pancreatic cancer.

Cancer Connect

Treatment of Stage IV - Metastatic Pancreatic Cancer

Treatment is with precision medicines & chemotherapy - genomic biomarker testing should be performed in all patients.

Cancer Connect

Early Activity in Pancreatic Cancer with Adavosertib

Experimental Gemzar-Adavosertib- Radiation combination promising for treatment of locally advanced pancreatic cancer.

MedMaven

NRG 1 Fusion Genes Can be Targeted with the MCLA-128 Bispecific Antibody

Responses to MCLA-128 reported in patients with pancreatic ductal adenocarcinoma and non-small cell lung cancer.

MedMaven

Pancreatic Cancer Screening, Early Detection and Prevention

The latest genetic-genomic advances defining who should undergo screening for the early detection of pancreatic cancer.

Cancer Connect

by

Eira

BL- 8040 - A Novel CXCR4 Blocking Agent for Pancreatic Cancer

Triplet immunotherapy - BL-8040 combination shows promising responses in metastatic pancreatic cancer.

MedMaven

Data Associating Being Overweight with Increased Risk of Pancreatic Cancer

Further Data Associating Being Overweight with Increased Risk of Pancreatic Cancer

Cancer Connect

by

Voluptate

FDA Approves Tarceva® in Combination with Gemzar® for Pancreatic Cancer

FDA Approves Tarceva® in Combination with Gemzar® for Pancreatic Cancer

Cancer Connect